Description
Evrizam Capsules 400 mg/25 mg.
Overview
Evrizam is a combination medication that contains two active ingredients: piracetam and cinnarizine. Piracetam is a nootropic agent that is believed to enhance cognitive function, while cinnarizine is an antihistamine and calcium channel blocker that is used to treat vertigo and other vestibular disorders. The combination of these two ingredients in Evrizam capsules aims to provide a synergistic therapeutic effect.
Uses
Evrizam capsules are primarily used for the following conditions:
- Improving cognitive function and memory
- Alleviating symptoms of vertigo and dizziness
- Enhancing focus and concentration
- Supporting overall brain health
It is important to note that Evrizam should only be used as prescribed by a healthcare professional, and the dosage and duration of treatment may vary depending on the specific condition being treated.
Dosage and Administration
The recommended dosage of Evrizam capsules is typically one capsule (400 mg. piracetam/25 mg. cinnarizine) taken orally, one to three times a day, or as directed by your doctor. It is important to follow the prescribed dosage and administration instructions carefully to ensure the optimal therapeutic benefit of the medication.
Evrizam capsules should be swallowed whole with a glass of water and can be taken with or without food, depending on individual preferences. Do not crush or chew the capsules, as this may affect the absorption of the medication.
Side Effects
As with any medication, Evrizam capsules may cause side effects in some individuals. Common side effects of Evrizam may include:
- Headache
- Nausea
- Dizziness
- Insomnia
- Gastrointestinal discomfort
If you experience any severe or persistent side effects while taking Evrizam capsules, it is important to seek medical advice promptly. Do not discontinue the medication without consulting your healthcare provider.
Precautions
Before taking Evrizam capsules, inform your doctor about any existing medical conditions, allergies, or medications you are currently taking. It is important to disclose this information to ensure the safe and effective use of Evrizam and to prevent potential drug interactions or adverse effects.
Additionally, certain populations, such as pregnant or breastfeeding women, individuals with liver or kidney impairment, or those with a history of sensitivity to piracetam or cinnarizine, may require special precautions or dosage adjustments when using Evrizam. Consult with your healthcare provider for personalized guidance.
Storage
Store Evrizam capsules in a cool, dry place away from direct sunlight and moisture. Keep the medication out of reach of children and pets. Do not use Evrizam capsules beyond the expiration date printed on the packaging.
Conclusion
In conclusion, Evrizam capsules containing 400 mg. of piracetam and 25 mg. of cinnarizine offer a combination therapy for cognitive enhancement and vestibular disorder management. By following the prescribed dosage, administration instructions, and precautions, patients can benefit from the therapeutic effects of Evrizam while minimizing the risk of potential side effects.
Remember to consult with your healthcare provider for personalized advice on using Evrizam capsules and to address any concerns or questions you may have regarding this medication.
